Previous 10 | Next 10 |
Summary 2 out of 23 CEF sectors were positive on price and 2 out of 23 sectors were positive on NAV last week. VFL offers tender results. Why it pays to monitor your CEF holdings for corporate actions. Author's note: This article was released to CEF/ETF Income Laborato...
Summary We share data on over 50 big-yield healthcare investments, including individual stocks, REITs, closed-end funds ("CEFs") and bonds. We dive deeper into three specific attractive big-yield opportunities that also have healthy upside potential. We begin with a special focus on...
The Board of Trustees of The Gabelli Healthcare & Wellness Rx Trust (NYSE:GRX) (the “Fund”) declared a $0.15 per share cash distribution payable on December 16, 2022 to common shareholders of record on December 9, 2022. The Fund intends to pay a quarterly distr...
We previously discussed Buffett's explanation for why smart people go broke. We then made the connection to why we generally don't buy CEFs. However, this does not mean that investors should never buy any CEFs under any circumstances. Back in March, we wrote : ...
GRX’s total return has been negative, and yield has been quite average over the short term. GRX failed to record double digit average total return over the medium and long term. GRX has a quite high expense ratio and doesn’t have significant investments in any one st...
Discounts have been widening in the CEF space as volatility has been kicking up. The widening discounts have been creating more opportunities, but headwinds exist. We screen for several different metrics that bring up funds worth exploring further. For further details see: ...
1 out of 22 CEF sectors positive on price and 1 out of 22 sectors positive on NAV last week. GUT has completed its rights offering, which was oversubscribed. Sidestepping the offering was once again the optimal strategy. For further details see: Weekly Closed-End Fund Ro...
Warren Buffett once listed the only 3 ways that a smart person can go broke. We zero in on one of those reasons to explain why it is so dangerous for investors. We then make the connection to why we don't buy CEFs. For further details see: Buffett Warns Of How Smart Peop...
BME is highly concentrated on large caps, but it is yet to recover from the pandemic. It has low dividend yield, thus not suitable for income-seeking investors. Short- and medium-term returns are low when compared with its peers. For further details see: BME: High Concen...
GRX’s return has replicated the S&P 500 index, but has always performed less than the index. Market has boomed from its pandemic time bottom, but the healthcare & food sector lags in recovery. GRX tends to have low risk due to controlled movements and good liquidity...
News, Short Squeeze, Breakout and More Instantly...
The Gabelli Healthcare & Wellness Trust of Beneficial Interest Company Name:
GRX Stock Symbol:
NYSE Market:
The Gabelli Healthcare & Wellness Trust of Beneficial Interest Website:
2024-07-02 00:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-21 12:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-21 23:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...